"July 6, 2015 -- About 21 million Americans have used prescription heartburn medications called proton pump inhibitors to help ease pain and discomfort after they eat. But does that help come at a price?
A recent study found that the drugs, "...
Kapidex Delayed Release Capsules
There have been no reports of significant overdose of KAPIDEX (dexlansoprazole delayed release capsules) . Multiple doses of KAPIDEX (dexlansoprazole delayed release capsules) 120 mg and a single dose of KAPIDEX (dexlansoprazole delayed release capsules) 300 mg did not result in death or other severe adverse events. Dexlansoprazole is not expected to be removed from the circulation by hemodialysis. If an overdose occurs, treatment should be symptomatic and supportive.
KAPIDEX (dexlansoprazole delayed release capsules) is contraindicated in patients with known hypersensitivity to any component of the formulation [see DESCRIPTION]. Hypersensitivity and anaphylaxis have been reported with KAPIDEX use [see ADVERSE REACTIONS].This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 4/14/2010
Additional Kapidex Delayed Release Capsules Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.